NDRA — ENDRA Life Sciences Share News
0.000.00%
Last trade - 00:00Endra Life Sciences Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results
Endra Life Sciences Inc Expected To Post A Loss Of $4.08 A Share: Earnings Preview
U.S. RESEARCH ROUNDUP-Lowe's Companies, Netflix, Vulcan Materials
Endra Life Sciences Inc Expected To Post A Loss Of $4.10 A Share: Earnings Preview
Brief: Endra Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement
Endra Life Sciences Inc Reports Results For The Quarter Ended September 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of $62.30 A Share: Earnings Preview
Brief: Endra Life Sciences Activates Taeus System To Initiate Clinical Study At Lmu University Hospital In Germany
Endra Life Sciences Inc Expected To Post A Loss Of $2.00 A Share: Earnings Preview
Brief: Endra Life Sciences Announces Reverse Stock Split
Endra Life Sciences Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Endra Life Sciences Announces Leadership Changes
Endra Life Sciences Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Endra Life Sciences Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: S.H.N. Financial Investments Ltd. Reports 9.99% Passive Stake In Endra Life Sciences Inc As Of June 4, 2024- SEC Filing
Brief: ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
Brief: Endra Provides Update Following In-Person Meeting With FDA
Endra Life Sciences Inc Reports Results For The Quarter Ended In March: Earnings Summary